Fortress Biotech, Inc. (FBIO) Stock

Fortress Biotech, Inc. (FBIO) is a Healthcare stock trading at $3.00 (as of 2026-06-18), with a market capitalization of $90.77M and a trailing P/E of 0.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Fortress Biotech, Inc. develops, and commercializes pharmaceutical and biotechnology products. It markets dermatology therapies and related products, including capsules and creams for conditions such as acne, ringworm/jock itch symptoms, dry skin, and wound management, and also develops late-stage and earlier-stage product candidates across multiple therapeutic areas.

Valuation — source: SEC EDGAR (first-party)
Price$3.00
Market Cap$90.77M
P/E Ratio0.9
EV / EBITDA2.2
Price / Book0.49
Price / Sales1.50
Dividend Yield0.5%
DCF Value (model)$-34.80
DCF Upside vs Price-1260.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$63.26M
Net Margin10.8%
Return on Equity63.1%
Debt / Equity0.19
Current Ratio2.86
Revenue Growth (YoY)22.1%
EPS Growth (YoY)-816.7%
Financial Health — source: SEC EDGAR
Altman Z-Score-5.51 (distress)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Stock P/E0.9
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-95.6%
vs Industry-94.6%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($4.03M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOLindsay Allan Rosenwald
Employees101
CountryUS
IPO Date2011-11-17

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Sol-Gel Technologies Ltd. (SLGL)
  • Inovio Pharmaceuticals, Inc. (INO)
  • Cognition Therapeutics, Inc. (CGTX)
  • Spruce Biosciences, Inc. (SPRB)
  • Eledon Pharmaceuticals, Inc. (ELDN)
  • Fate Therapeutics, Inc. (FATE)
  • Oramed Pharmaceuticals Inc. (ORMP)
  • Agenus Inc. (AGEN)
FBIO earnings history · FBIO institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.